Northrop Grumman Corporation
NYSE:NOCAerospace & Defense
-$32.91 today
- Market cap
- $77.14B
- Beta
- -0.12
- P/E (TTM)
- 16.1
- EPS (TTM)
- $32.20
- Dividend yield
- 1.82%
Volume 0.86M
Average 0.86M
NOC Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Northrop Grumman CorporationNYSE: NOC
Accounts Receivables · Q3 FY2026 · quarter ended Sep 2026
Accounts receivables turns negative
Q3 FY2026 accounts receivables was -$86M, compared with $487M a year earlier. Trailing-twelve-month accounts receivables was -$965M. Over 3 fiscal years it compounded at +34.9% a year.
Context
- Accounts receivables amounted to 0.3% of revenue in FY2025, up 0.2 pp from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts receivables holds near -$86M or moves back toward the trailing-twelve-month quarterly average of -$241.25M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (108M) USD
- Year-over-year change
- -227.3%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (108M) | -227.3% |
| FY2024 | 2024-12-31 | (33M) | -161.1% |
| FY2023 | 2023-12-31 | 54M | +222.7% |
| FY2022 | 2022-12-31 | (44M) | -340.0% |
| FY2021 | 2021-12-31 | (10M) | — |
Accounts Receivables vs competitors
How NOC compares with its peers on the latest reported figures
- NOC's LTM Sep 2026 accounts receivables of $965M is the 4th largest of the 7 companies compared; the peer median is $282M.
- Its year-over-year change of -517.7% is the lowest of 7, against a peer median of +22.9%.
- Accounts receivables amounts to 2.2% of revenue for NOC, versus a peer median of 2.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $4.07B | +79.4% | — | 4.2% | |
| LTM Sep 2026 | $1.54B | +113.7% | +50.1% | 2.0% | |
| LTM Oct 2026 | $1.16B | +1513.9% | +129.5% | 2.1% | |
| LTM Sep 2026 | $965M | -517.7% | +34.9% | 2.2% | |
| LTM Jul 2026 | $593M | -33.6% | +54.9% | 2.6% | |
| LTM Jun 2026 | $542M | -139.1% | — | 0.6% | |
| LTM Jun 2026 | $22M | -110.3% | +1.0% | 0.2% | |
| Peer median (excluding NOC) | $282M | +22.9% | +52.5% | 2.0% | |
Competitors are the stored peer set for NOC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 7.01B | 4.9B | 2.06B | 4.17B | 4.18B |
| Depreciation & Amortization | 1.24B | 1.34B | 1.34B | 1.37B | 1.47B |
| Deferred Income Tax | 603M | (321M) | (988M) | (582M) | 548M |
| Stock-Based Compensation | 94M | 99M | 87M | 101M | 119M |
| Change in Working Capital | 181M | (600M) | (144M) | 335M | (863M) |
| Accounts Receivables | (10M) | (44M) | 54M | (33M) | (108M) |
| Inventory | (52M) | (205M) | (220M) | (358M) | 97M |
| Accounts Payables | 376M | 572M | 519M | (513M) | 646M |
| Other Working Capital | (133M) | (923M) | (497M) | 1.24B | (1.5B) |
| Other Non-Cash Items | (5.56B) | (2.52B) | 1.53B | (1.01B) | (701M) |
| Operating Cash Flow | 3.57B | 2.9B | 3.88B | 4.39B | 4.76B |
| Capital Expenditures | (1.42B) | (1.44B) | (1.78B) | (1.77B) | (1.45B) |
| Acquisitions (Net) | 3.4B | 155M | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 197M | 0 | 0 |
| Other Investing Activities | 73M | 39M | (4M) | 18M | 295M |
| Investing Cash Flow | 2.06B | (1.24B) | (1.58B) | (1.75B) | (1.16B) |
| Debt Repayment | (2.24B) | 0 | 945M | 2.5B | (502M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (3.71B) | (1.5B) | (1.5B) | (2.51B) | (1.62B) |
| Dividends Paid | (983M) | (1.05B) | (1.12B) | (1.19B) | (1.29B) |
| Other Financing Activities | (78M) | (57M) | (90M) | (190M) | (133M) |
| Financing Cash Flow | (7B) | (2.61B) | (1.76B) | (1.4B) | (3.55B) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (1.38B) | (953M) | 532M | 1.24B | 50M |
| Free Cash Flow | 2.15B | 1.47B | 2.1B | 2.62B | 3.31B |
Northrop Grumman Corporation
NYSE:NOC
Intrinsic Alpha fair value
Locked
Current Price
$542.99
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.